Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07QIP
|
|||
Drug Name |
4-(thiazol-5-yl)-pyrimidine derivative 1
|
|||
Synonyms |
PMID26161698-Compound-35
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE UNIVERSITY OF NOTTINGHAM WANG, Shudong SHI, Shenhua ZAYTSEV, Andrey FISCHER, Peter MartiCYCLACEL LIMITED WANG, Shudong MEADES, Christopher WOOD, Gavin OSNOWSKI, Andrew FISCHER, Peter, MartiCYCLACEL LIMITED FISCHER, Peter, Martin WANG, Shudong WOOD, Gavin
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H14N6OS
|
|||
Canonical SMILES |
CC1=C(SC(=N1)NC)C2=NC(=NC=C2C#N)NC3=CC(=CC=C3)O
|
|||
InChI |
1S/C16H14N6OS/c1-9-14(24-16(18-2)20-9)13-10(7-17)8-19-15(22-13)21-11-4-3-5-12(23)6-11/h3-6,8,23H,1-2H3,(H,18,20)(H,19,21,22)
|
|||
InChIKey |
NYRVLHGVDPPWJS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.